CHEPLAPHARM ARZNEIMITTEL GMBH 5.5 percent 15Jan2028 is a Senior Secured Note issued by the corporate entity on the 8th of October 2020. CHEPLAPHARM is trading at 90.75 as of the 28th of March 2025, a 1.33% up since the beginning of the trading day. The bond's open price was 89.56. CHEPLAPHARM has about a 36 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Ratings for CHEPLAPHARM ARZNEIMITTEL GMBH are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in CHEPLAPHARM without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Theme Ratings Now
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Other Information on Investing in CHEPLAPHARM Bond
CHEPLAPHARM financial ratios help investors to determine whether CHEPLAPHARM Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CHEPLAPHARM with respect to the benefits of owning CHEPLAPHARM security.